Skip to main content

TC BioPharm (Holdings) plc

TCBPDelisted Aug 8, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001872812

TC BioPharm (Holdings) plc was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Jan 11, 2023; 12 institutions reported holding it in 13F filings for Q3 2023, worth $179.6K in total; no superinvestor held it.

Q4 2023 vs. Q3 2023

How the institutions holding TC BioPharm (Holdings) plc changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of TCBP: Q3 2023 compared with Q4 2023
MeasureQ3 2023Of which not filed for Q4 2023Q4 2023Change
Holders1214−7
Shares436.1K2.00K76.9K−357.2K (−82.3%)
Value$179.6K$0$243.8K+$64.2K (+35.7%)

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (2)

Institutions that held TC BioPharm (Holdings) plc at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to TCBP in Q4 2023
InstitutionSharesValue% of portfolio
Tower Research Capital LLC (TRC)2,770$8.78K0.00%
JPMorgan Chase & Co89$2820.00%

Sold out (9)

Institutions that held TC BioPharm (Holdings) plc at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of TCBP in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Csenge Advisory Group26,000$11.2K
Cresset Asset Management, LLC25,000$10.8K
Two Sigma Securities, LLC13,401$5.76K
XTX Topco Ltd13,617$5.68K
Citadel Advisors LLC13,543$5.65K
Renaissance Technologies LLC11,003$5.00K
UBS Group AG3,516$1.51K
Clear Street LLC1,323$569
Modera Wealth Management, LLC16,244–

Not filed for Q4 2023 yet (1)

Institutions that held TC BioPharm (Holdings) plc at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TCBP in Q3 2023 that haven't filed for Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Steward Financial Group LLC2,000$0